Researchers have characterized Cas12f orthologs, revealing features that enhance genome editing efficiency. A compact CRISPR system has been reported, with some outlets suggesting it may enable targeted in-body gene editing with high efficiency, although the exact efficiency rate is unclear. The development of this gene editing tool has been linked to potential therapeutic applications and has been reported in a Nature journal study by Metagenomi.